Neuland Laboratories witnessed a sharp decline in its share price, falling nearly 5% after the company reported a disappointing set of numbers for the fourth quarter. As of 9:30 AM, the shares were trading 4.38% lower at Rs 11,340.00.
The company’s revenue dropped 14.8% year-on-year to ₹328 crore, compared to ₹385 crore in the same quarter last year. Operating performance took a steeper hit, with EBITDA plunging 52.3% to ₹51 crore from ₹107 crore, reflecting a substantial reduction in profitability. Consequently, the EBITDA margin narrowed to 15.6% from 27.8%, signaling rising costs or reduced operational efficiency.
Net profit also saw a steep decline of 58.8%, coming in at ₹28 crore against ₹68 crore a year ago.
Neuland Laboratories shares opened at ₹11,050 today, reaching a high of ₹11,469 and dipping to a low of ₹10,578 during trading. Despite current fluctuations, the stock has shown significant volatility over the year, with a 52-week high of ₹18,100 and a low of ₹5,540.10.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.